94 results
Page 2 of 5
8-K
EX-1.1
li53k
12 Oct 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:46pm
424B5
q7c0g3 u99yn
8 Oct 21
Prospectus supplement for primary offering
5:13pm
424B5
5137xn xaoq6o
6 Oct 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-10.1
kz55gp4f f9
6 Oct 21
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-1.1
2gqlb6m0e3f99ydcy
8 Sep 21
Other Events
7:10am
424B5
rok ip99ut0gj3s7tadj
8 Sep 21
Prospectus supplement for primary offering
7:01am
8-K
EX-99.3
9d84 ntj6m
8 Sep 21
Other Events
6:22am
8-K
EX-99.2
pqopar0w5gdws5i8
8 Sep 21
Other Events
6:22am
8-K
EX-2.1
nfo tqidg9r1eribg
30 Jun 21
Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC
6:04am
8-K
EX-99.1
mp69wbs144
30 Mar 21
Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
12:00am
8-K
EX-99.1
nacchy n4v
10 Nov 20
Osmotica Pharmaceuticals plc Reports Third Quarter 2020 Results and Provides Business Updates
4:23pm
8-K
EX-99.2
0hmzke2
11 Aug 20
Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business Updates
4:40pm